| Price | 15.00p on 02-06-2026 at 16:55:09 |
|---|---|
| Change | 0.00p 0% |
| Buy | 15.50p |
| Sell | 14.50p |
| Last Trade: | Buy 24,603.00 at 15.25p |
| Day's Volume: | 534,743 |
| Last Close: | 15.00p |
| Open: | 15.00p |
| ISIN: | CA68234M2058 |
| Day's Range | 15.00p - 15.00p |
| 52wk Range: | 8.00p - 18.25p |
| Market Capitalisation: | £77.93m |
| VWAP: | 15.03603p |
| Shares in Issue: | 519.55m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ondine Biomed (OBI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 24,603 | 15.25p | Ordinary |
15:00:41 - 02-Jun-26 |
| Buy* | 19,645 | 15.24p | Ordinary |
12:19:07 - 02-Jun-26 |
| Buy* | 9,500 | 15.24p | Ordinary |
12:17:28 - 02-Jun-26 |
| Buy* | 14 | 15.50p | SI Trade |
12:13:39 - 02-Jun-26 |
| Sell* | 25,000 | 14.80p | Ordinary |
11:11:19 - 02-Jun-26 |
| Unknown* | 50,000 | 14.855p | Ordinary |
11:04:20 - 02-Jun-26 |
| Sell* | 1,816 | 14.50p | Ordinary |
10:28:49 - 02-Jun-26 |
| Buy* | 32 | 15.50p | Ordinary |
09:30:09 - 02-Jun-26 |
| Sell* | 3,300 | 14.855p | Ordinary |
09:18:19 - 02-Jun-26 |
| Unknown* | 30,288 | 15.00p | Negotiated Trade |
09:00:26 - 02-Jun-26 |
Ondine Biomed (OBI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 28th May 2026 7:00 am | RNS | Notice of Results and Investor Presentation |
| 26th May 2026 11:00 am | RNS-R | Steriwave ICU Study Outcomes Presented at CSRT2026 |
| 6th May 2026 9:54 am | RNS | Notification of major holdings - hInsight-NX, LLC |
| 6th May 2026 9:47 am | RNS | Notification of major holdings - Carolyn Cross |
| 5th May 2026 5:02 pm | RNS | Notification of major holdings - Pentwater |
| 30th Apr 2026 9:30 am | RNS-R | Ondine Presented Steriwave Data at IPC 2026 |
| 29th Apr 2026 7:00 am | RNS | Result of Fundraise & TVR |
| 28th Apr 2026 5:26 pm | RNS | Proposed c.£5 million (C$9.23 million) Fundraise |
| 27th Apr 2026 7:00 am | RNS-R | ICU Study to be Presented at 2026 CACCN Conference |
| 23rd Apr 2026 7:00 am | RNS | Marked Reduction in SSIs at Ottawa Heart Institute |